398 related articles for article (PubMed ID: 10233384)
1. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
[TBL] [Abstract][Full Text] [Related]
2. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.
Grimwade D; Howe K; Langabeer S; Davies L; Oliver F; Walker H; Swirsky D; Wheatley K; Goldstone A; Burnett A; Solomon E
Br J Haematol; 1996 Sep; 94(3):557-73. PubMed ID: 8790159
[TBL] [Abstract][Full Text] [Related]
3. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements.
Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF
Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918
[TBL] [Abstract][Full Text] [Related]
4. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP
Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596
[TBL] [Abstract][Full Text] [Related]
5. New rearrangement t(3;17)(q26.3;q12) in an AML patient with a poor outcome.
Macedo Silva ML; Land M; Heller A; Abdelhay E; do Socorro Pombo-de-Oliveira M; Ribeiro R; Alves G; Lerner D; Liehr T
Oncol Rep; 2005 Sep; 14(3):663-6. PubMed ID: 16077971
[TBL] [Abstract][Full Text] [Related]
6. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
Eclache V; Viguie F; Frocrain C; Cassinat B; Chomienne C; Cymbalista F; Fenaux P
Cancer Genet Cytogenet; 2005 May; 159(1):69-73. PubMed ID: 15860361
[TBL] [Abstract][Full Text] [Related]
7. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
Diverio D; Riccioni R; Mandelli F; Lo Coco F
Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
[TBL] [Abstract][Full Text] [Related]
8. The significance of minimal residual disease in patients with t(15;17).
Grimwade D
Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of dual fusion PML/RARalpha translocation DNA probe (D-FISH) in acute promyelocytic leukemia.
Wan TS; So CC; Hui KC; Yip SF; Ma ES; Chan LC
Oncol Rep; 2007 Apr; 17(4):799-805. PubMed ID: 17342318
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescence in situ hybridization study of acute myeloid leukemia with cryptic chromosome rearrangements].
Bai SX; Xue YQ; Chen SN; Pan JL; Wu YF; Shen J; Wang Y; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):690-3. PubMed ID: 22161107
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
Grimwade D; Gorman P; Duprez E; Howe K; Langabeer S; Oliver F; Walker H; Culligan D; Waters J; Pomfret M; Goldstone A; Burnett A; Freemont P; Sheer D; Solomon E
Blood; 1997 Dec; 90(12):4876-85. PubMed ID: 9389704
[TBL] [Abstract][Full Text] [Related]
12. Identification of signature genes by microarray for acute myeloid leukemia without maturation and acute promyelocytic leukemia with t(15;17)(q22;q12)(PML/RARalpha).
Morikawa J; Li H; Kim S; Nishi K; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W; Kobayashi T
Int J Oncol; 2003 Sep; 23(3):617-25. PubMed ID: 12888896
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML).
Falini B; Flenghi L; Fagioli M; Lo Coco F; Cordone I; Diverio D; Pasqualucci L; Biondi A; Riganelli D; Orleth A; Liso A; Martelli MF; Pelicci PG; Pileri S
Blood; 1997 Nov; 90(10):4046-53. PubMed ID: 9354674
[TBL] [Abstract][Full Text] [Related]
14. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
[TBL] [Abstract][Full Text] [Related]
15. Haematological & molecular profile of acute myelogenous leukaemia in India.
Sazawal S; Kumar B; Hasan SK; Dutta P; Kumar R; Chaubey R; Mir R; Saxena R
Indian J Med Res; 2009 Mar; 129(3):256-61. PubMed ID: 19491417
[TBL] [Abstract][Full Text] [Related]
16. Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia.
Ismail S; Ababneh N; Awidi A
Acta Haematol; 2007; 118(3):183-7. PubMed ID: 17934255
[TBL] [Abstract][Full Text] [Related]
17. Two new 3' PML breakpoints in t(15;17)(q22;q21)-positive acute promyelocytic leukemia.
Chillón MC; González M; García-Sanz R; Balanzategui A; González D; López-Pérez R; Mateos MV; Alaejos I; Rayón C; Arbeteta J; Hernández JM; Orfao A; San Miguel J
Genes Chromosomes Cancer; 2000 Jan; 27(1):35-43. PubMed ID: 10564584
[TBL] [Abstract][Full Text] [Related]
18. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
García-Casado Z; Cervera J; Valencia A; Pajuelo JC; Mena-Duran AV; Barragán E; Bolufer P; Sanz MA
Cancer Genet Cytogenet; 2006 Jul; 168(1):73-6. PubMed ID: 16772124
[TBL] [Abstract][Full Text] [Related]
19. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
20. Clonal expanded TCR Vbeta T cells in patients with APL.
Li Y; Chen S; Yang L; Zhou Y; Wu X; Huang M; Geng S
Hematology; 2005 Apr; 10(2):135-9. PubMed ID: 16019459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
